Skip to content

Abstract 15004: Multicentre Evaluation of Quantitative and Qualitative RV Echocardiographic Markers for Mortality

Nov 2026 · Circulation · 0 citations

Abstract

Background: Right ventricular (RV) dysfunction is an important predictor of adverse clinical outcomes. Historically, RV parameters have not been included in echocardiographic mortality prediction models. Thus, the value of these measures for predicting mortality remains incompletely defined. Research Question: To determine the impact of qualitative versus quantitative RV echocardiographic parameters on mortality prediction. Methods: A multicentre echocardiographic database (University Health Network, St. Michael’s Hospital, and London Health Sciences Centre) linked to outcome data at ICES was used. Adults with RV qualitative (normal, mild, moderate and severe) and quantitative parameters (tricuspid annular plane systolic excursion, TAPSE; RV S’; RV systolic pressure, RVSP) were identified. Patients with congenital heart disease, prior valve surgery, cardiac devices, transplantation, and duplicate studies were excluded. Outcomes included 30-day and 1-year all-cause and cardiovascular mortality. Restricted cubic spline analyses were used to allow for nonlinear associations between RV parameters and mortality. After developing multivariable models adjusted for age, sex, and left ventricular ejection fraction (LVEF), a mortality risk score was developed. Results: The cohort included 22,693 patients (patient characteristics in Table 1). All-cause mortality occurred in 3.9% at 30 days and 13.4% at 1 year; cardiovascular mortality occurred in 1.6% and 4.5%, respectively. Qualitative RV assessment was associated with all-cause mortality (c-statistic 0.677) and cardiovascular mortality (0.790) at 1 year (both p<0.001). Quantitative univariate RV assessment demonstrated nonlinear associations with all cause and cardiovascular mortality (Figure 1). Lower TAPSE, RV S’, and higher RVSP were associated with increased rates of adverse outcomes. Quantitative age-, sex-, and LVEF- adjusted models with TAPSE or RV S’ or RVSP outperformed qualitative RV age-, sex-, and LVEF- adjusted models for all-cause mortality at 30 days (c-statistics 0.78 p<0.001) and 1 year (0.74, p<0.001). Similar findings were observed for cardiovascular mortality (c-statistics 0.78, p<0.001 at 30 days; 0.81, p<0.001 at 1 year). A mortality risk score was developed and maintained stable discrimination across serial echocardiographic studies (AUC 0.74, 95% CI 0.72-0.76). Conclusions: This is the first study to demonstrate that addition of RV echocardiographic parameters to age-, sex- and LVEF- adjusted models improves mortality risk discrimination and the use of quantitative parameters are superior to that of qualitative assessment. An echocardiographic mortality risk score that incorporates RV quantitative parameters improves risk stratification. Prospective testing of the risk score is needed to further evaluate its predictive value and role in clinical decision making.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.